Retrospective Evaluation of CroFab - Efficacy in Severe Envenomation
Retrospective observational review of severe envenomation treatment with CroFab
|Study Design:||Observational Model: Cohort
Time Perspective: Retrospective
|Official Title:||Retrospective Evaluation of Treatments and Outcomes Associated With Antivenom Therapy For Crotaline Snakebite - A Comparison Of Severe To Mild/Moderate Envenomations|
- Severity score: in order to assess response to therapy, severity scores were calculated and compared across all recorded time points. [ Time Frame: at baseline and following treatment with CroFab ] [ Designated as safety issue: No ]
- The presence of venom effects, comparison of venom effects over time, initial control of venom effects, recurrence of venom effects, and delayed onset of venom effects. [ Time Frame: following treatment ] [ Designated as safety issue: No ]
|Study Start Date:||January 2005|
|Study Completion Date:||December 2005|
Patients with a calculated severity score of 5 or 6 were included in this group.
Severity Score less than 5
The objective of this study is to use previously collected retrospective observational data to compare treatment and outcome in patients treated with CroFab who have a severe envenomation to those with a mild/moderate envenomation.
|United States, Colorado|
|Rocky Mountain Poison and Drug Center|
|Denver, Colorado, United States, 80204|
|Principal Investigator:||Richard C Dart, MD, PhD||Rocky Mountain Poison and Drug Center|